{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:31:14Z","timestamp":1775197874594,"version":"3.50.1"},"reference-count":30,"publisher":"California Digital Library (CDL)","issue":"4","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WestJEM"],"abstract":"<jats:p>Introduction: Synthetic cannabinoids are a rapidly expanding subset of designer drugs widely available in the United States since 2008. In Illinois during the spring of 2018, over 160 documented cases of bleeding and prolonged coagulopathy occurred secondary to contaminated synthetic cannabinoids. Methods: We conducted a retrospective cohort study consisting of 38 patients to describe the initial emergency department (ED) presentation, diagnosis, and treatment. Results: Through serum testing we found that three long-acting anticoagulant rodenticides (LAAR) were detected in patients who had inhaled these tainted products: brodifacoum, difenacoum, and bromodialone. Discussion: This study encompasses the largest ED presentation of LAAR poisoning via the inhalational route known to date. Conclusion: The emergency physician should be aware of the potential for tainted coingestants as the cause of undifferentiated coagulopathy.<\/jats:p>","DOI":"10.5811\/westjem.2021.2.46317","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T18:33:56Z","timestamp":1627238036000},"page":"1014-1019","source":"Crossref","is-referenced-by-count":6,"title":["Severe Vitamin K-dependent Coagulopathy from Rodenticide-contaminated Synthetic Cannabinoids: Emergency Department Presentations"],"prefix":"10.5811","volume":"22","author":[{"given":"Erik","family":"Wright","sequence":"first","affiliation":[{"name":"University of Illinois College of Medicine Peoria, OSF Saint Francis Medical Center, Department of Emergency Medicine, Peoria, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hafner","sequence":"additional","affiliation":[{"name":"University of Illinois College of Medicine Peoria, Department of Emergency Medicine, Peoria, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Podolej","sequence":"additional","affiliation":[{"name":"University of Illinois College of Medicine Peoria, Department of Emergency Medicine, Peoria, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Feinstein","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago, Jesse Brown VA Medical Center, Department of Anesthesiology, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"van Breemen","sequence":"additional","affiliation":[{"name":"Oregon State University, Linus Pauling Institute, Department of Pharmaceutical Sciences, Corvallis, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Rubinstein","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago, Jesse Brown VA Medical Center, Division of Pulmonary, Critical Care, Sleep, and Allergy Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Aks","sequence":"additional","affiliation":[{"name":"Rush University, Department of Emergency Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wahl","sequence":"additional","affiliation":[{"name":"John H. Stroger Hospital of Cook County, Department of Emergency Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"29705","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Albertson T. Recreational drugs of abuse. Clinic Rev Allerg Immunol. 2014;46(1):1-2.","DOI":"10.1007\/s12016-013-8382-y"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Davis GG. Drug abuse: Newly emerging drugs and trends. Clin Lab Med. 2012;32(3):407-14.","DOI":"10.1016\/j.cll.2012.06.002"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Karila L, Benyamina A, Blecha L, et al. The synthetic cannabinoids phenomenon. Curr Pharm Des. 2016;22(42):6420-5.","DOI":"10.2174\/1381612822666160919093450"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging \u2018incense\u2019 and \u2018bath salt\u2019 phenomenon. Cleve Clin J Med. 2012;79(4):258-64.","DOI":"10.3949\/ccjm.79a.11147"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Bernson-Leung M, Leung L, Kumar S. Synthetic cannabis and acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(5):1239-41.","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.07.030"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Khanagavi J, Phatak P, Kolte D, Aronow WS, Lanier G. Synthetic cannabinoids-induced thrombotic microangiopathy leading to acute heart failure. Circulation. 2013;128(22).","DOI":"10.1161\/circ.128.suppl_22.A18135"},{"key":"ref6","unstructured":"Nocerino A, Ilyas N. Unusual toxicities of synthetic marijuana. J Gen Intern Med. 2016;31(2):S776."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Ozturk E, Oral A, Ozdemir M, et al. Synthetic marijuana \u201cK2\u201d induced ITP. Platelets. 2015;26(3):258-9.","DOI":"10.3109\/09537104.2014.898263"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Sherpa D, Paudel BM, Subedi BH, et al. Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high. J Community Hosp Intern Med Perspect. 2015;5(4):27540.","DOI":"10.3402\/jchimp.v5.27540"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Solimini R, Rotolo MC, Pellegrini M, et al. Adulteration practices of psychoactive illicit drugs: an updated review. Curr Pharm Biotechnol. 2017;18(7):524-30.","DOI":"10.2174\/1389201018666170710184531"},{"key":"ref10","unstructured":"La Rosa FG, Clarke SH, Lefkowitz JB. Brodifacoum intoxication with marijuana smoking. Arch Pathol Lab Med. 1997;121(1):67-9."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Waien SA, Hayes D,Jr, Leonardo JM. Severe coagulopathy as a consequence of smoking crack cocaine laced with rodenticide. N Engl J Med. 2001;345(9):700-1.","DOI":"10.1056\/nejm200108303450916"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Tecimer C, Yam LT. Surreptitious superwarfarin poisoning with brodifacoum. South Med J. 1997;90(10):1053-5.","DOI":"10.1097\/00007611-199710000-00018"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Damkier P, Lassen D, Christensen MMH, Madsen KG, Hellfritzsch M, Pottegard A. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol. 2019;124(1):28-31.","DOI":"10.1111\/bcpt.13152"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim JH, Kim HS, Kong TY, et al. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s. J Pharm Biomed Anal. 2016;119:50-8.","DOI":"10.1016\/j.jpba.2015.11.023"},{"key":"ref15","unstructured":"Illinois Department of Public Health. More synthetic cannabinoids cases. 2018. http:\/\/dph.illinois.gov\/news\/more-synthetic-cannabinoids-cases. Accessed September 28, 2018."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Connors JM. Hemorrhagic highs from synthetic cannabinoids\u2014 a new epidemic. N Engl J Med. 2018;379(13):1275-7.","DOI":"10.1056\/nejme1810418"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Moritz E, Austin C, Wahl M, et al. Notes from the field: outbreak of severe illness linked to the vitamin K antagonist brodifacoum and use of synthetic cannabinoids \u2014 Illinois, March\u2013April 2018. MMWR Morb Mortal Wkly Rep. 2018;67(21):607\u20138.","DOI":"10.15585\/mmwr.mm6721a4"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kelkar AH, Smith NA, Martial A, et al.\u00a0An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois. N Engl J Med. 2018;379(13):1216-23.","DOI":"10.1056\/nejmoa1807652"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Devgun JM, Rasin A, Kim T, et al. An outbreak of severe coagulopathy from synthetic cannabinoids tainted with long-acting anticoagulant rodenticides. Clin Toxicol (Phila). 2019;1-8.","DOI":"10.1080\/15563650.2019.1690149"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Bruno GR, Howland MA, McMeeking A, et al. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med. 2000;36(3):262-7.","DOI":"10.1067\/mem.2000.108317"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Damkier P, Lassen D, Christensen MMH, et al. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol. 2019;124(1):28-31.","DOI":"10.1111\/bcpt.13152"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Yamreudeewong W, Wong HK, Brausch LM, et al. Probable interaction between warfarin and marijuana smoking. Ann Pharmacother. 2009;43(7):1347-53.","DOI":"10.1345\/aph.1m064"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Waien SA, Hayes D, Leonardo JM. Severe coagulopathy as a consequence of smoking crack cocaine laced with rodenticide. N Engl J Med. 2001;345(9):700-1.","DOI":"10.1056\/nejm200108303450916"},{"key":"ref24","unstructured":"La Rosa FG, Clarke SH, Lefkowitz JB. Brodifacoum intoxication with marijuana smoking. Arch Pathol Lab Med. 1997;121(1):67-9."},{"key":"ref25","unstructured":"Health alert network (HAN) advisory released on May 25, 2018: Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use https:\/\/Emergency.cdc.gov\/han\/han00410.asp. 27;379(13):1216-23."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315-52.","DOI":"10.1016\/j.chest.2016.08.1442"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Doyle RJ, Elfessi Z, Kolman K. Fixed dose 4-factor prothrombin complex concentrate for bleeding caused by long acting anticoagulant rodenticides. Am J Emerg Med. 2018;36(10);1922.e3-1922.e4.","DOI":"10.1016\/j.ajem.2018.06.040"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Feinstein DL. Nosal DG, Swetha R, et al. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids. Clin Toxicol (Phila). 2020;58(7):716-24.","DOI":"10.1080\/15563650.2019.1687903"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Rubinstein I, Weinberg G, van Breemen R, et al. Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring? Toxicol Commun. 2018;2(1):59-61.","DOI":"10.1080\/24734306.2018.1500152"}],"container-title":["Western Journal of Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:27:43Z","timestamp":1725496063000},"score":1,"resource":{"primary":{"URL":"https:\/\/escholarship.org\/uc\/item\/5fb5p3dp"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,7,20]]}},"URL":"https:\/\/doi.org\/10.5811\/westjem.2021.2.46317","relation":{},"ISSN":["1936-900X"],"issn-type":[{"value":"1936-900X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,15]]}}}